Management of glucocorticoid-induced osteoporosis in rheumatic diseases
Best Practice & Research Clinical Rheumatology · 2026-09 · 40 (3) · 102151
DOI: 10.1016/j.berh.2026.102151 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Rheumatology, 2026-09. Verfasst von Pritee Shrestha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology, Medical College of Georgia at Augusta University, 1120 15th St, Augusta, GA, 30912, USA. Electronic…. Hauptthemen laut MEDLINE: Glucocorticoids, Osteoporosis, Rheumatic Diseases. Die Arbeit nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Augusta University Medical College of Georgia, National Institute on Aging.
Abstract (Originalsprache)
Glucocorticoid-induced osteoporosis (GIOP) and its attendant fractures are a major concern for patients with rheumatic diseases. This 2025 review highlights preventive and treatment strategies for GIOP. An overview of the epidemiology and pathogenesis of GIOP is discussed. Key questions considered are. (1) What are the optimum risk factor assessment strategies to identify patients with GIOP at fracture risk, including the role of clinical risk factors, imaging modalities and fracture risk calculators? (2). What are the preventive strategies for GIOP incorporating information on steroid-sparing agents for the treatment of rheumatic diseases, the role of calcium and vitamin D intake, and exercise ? (3). What are treatment strategies for GIOP with a focus on clinical trial data for FDA-approved therapies that have been studied in patients with rheumatic diseases? Clinical practice guidelines are discussed. Future directions for the prevention and treatment of GIOP in persons with rheumatic diseases are considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Rheumatology, Medical College of Georgia at Augusta University, 1120 15th St, Augusta, GA, 30912, USA. Electronic address: Pshrestha@augusta.edu.
- Department of Medicine, Division of Rheumatology, Medical College of Georgia at Augusta University, 1120 15th St, Augusta, GA, 30912, USA. Electronic address: Spopuri@augusta.edu.
- Department of Medicine, Division of Rheumatology, Medical College of Georgia at Augusta University, 1120 15th St, Augusta, GA, 30912, USA. Electronic address: choffer@augusta.edu.
- Department of Medicine, Division of Rheumatology, Medical College of Wisconsin, 5000 W National Ave, Milwaukee, WI, 53295, USA. Electronic address: Anqureshi@mcw.edu.
- Division of Endocrinology, Kaiser Permanente of Georgia, 3650 Steve Reynolds Blvd, Duluth, GA, 30096, USA. Electronic address: Joshua.Barzilay@kp.org.
- Department of Medicine, Division of Rheumatology, Medical College of Georgia at Augusta University, 1120 15th St, Augusta, GA, 30912, USA.
Förderung
- NIA NIH HHS
- Augusta University Medical College of Georgia
- National Institute on Aging
Zitieren
APA
Shrestha, P., Popuri, S. B., Hoffer, C., Qureshi, A., Barzilay, J., Dapaah, E. A., & Carbone, L. D. (2026). Management of glucocorticoid-induced osteoporosis in rheumatic diseases. Best Practice & Research Clinical Rheumatology, 40(3), 102151. https://doi.org/10.1016/j.berh.2026.102151
Vancouver
Shrestha P, Popuri SB, Hoffer C, Qureshi A, Barzilay J, Dapaah EA, et al. Management of glucocorticoid-induced osteoporosis in rheumatic diseases. Best Practice & Research Clinical Rheumatology. 2026;40(3):102151. doi:10.1016/j.berh.2026.102151
BibTeX
@article{Shrestha2026,
author = {Shrestha, Pritee and Popuri, Sowmya B and Hoffer, Colton and Qureshi, Anam and Barzilay, Joshua and Dapaah, Eunice Adu and Carbone, Laura D},
title = {Management of glucocorticoid-induced osteoporosis in rheumatic diseases},
journal = {Best Practice & Research Clinical Rheumatology},
year = {2026},
volume = {40},
number = {3},
pages = {102151},
doi = {10.1016/j.berh.2026.102151}
}
EUVIMED